CN Patent

CN115175679A — 治疗雌激素受体相关疾病的方法

Assigned to Olema Pharmaceuticals Inc · Expires 2022-10-11 · 4y expired

What this patent protects

本公开提供了治疗雌激素受体相关疾病、病症和疾患的方法。

USPTO Abstract

本公开提供了治疗雌激素受体相关疾病、病症和疾患的方法。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN115175679A
Jurisdiction: CN
Classification: —
Expires: 2022-10-11
Drug substance claim: No
Drug product claim: No
Assignee: Olema Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.